Volume 23, Number 4—April 2017
Dispatch
Incidence and Characteristics of Scarlet Fever, South Korea, 2008–2015
Table
Year, antimicrobial drug | emm type |
|||||
---|---|---|---|---|---|---|
emm1 | emm4 | emm12 | emm28 | Others | Total | |
2008 | ||||||
Tetracycline |
– |
1† |
– |
– |
– |
1† |
2009 | ||||||
Erythromycin | – | – | – | 2 | – | 2 |
Clindamycin | – | – | – | 2 | – | 2 |
Tetracycline |
– |
– |
– |
1 |
– |
1 |
2010 | ||||||
Erythromycin | – | – | – | 1 | – | 1 |
Clindamycin |
– |
– |
– |
1 |
– |
1 |
2011 | ||||||
Erythromycin | – | 1 | – | 1 | 1† | 1/3† |
Clindamycin | – | 1 | – | 1 | – | 2 |
Tetracycline |
– |
– |
– |
1 |
– |
1 |
2012 | ||||||
Erythromycin | – | – | – | 1 | – | 1 |
Clindamycin | – | 1 | – | 1 | – | 2 |
Tetracycline |
– |
1 |
– |
– |
– |
1 |
2013 | ||||||
Chloramphenicol | 1 | – | – | – | – | 1 |
Erythromycin | 1 | – | – | 2 | 1† | 1/4† |
Clindamycin | – | 1 | – | 2 | – | 3 |
Tetracycline |
– |
1 |
– |
1 |
– |
2 |
2014 | ||||||
Chloramphenicol | – | – | 1† | – | – | 1† |
Erythromycin | – | – | – | 4 | – | 4 |
Clindamycin | – | – | – | 4 | – | 4 |
Tetracycline |
– |
1† |
– |
4 |
– |
1/5† |
2015 | ||||||
Erythromycin | – | – | 1 | 5 | – | 6 |
Clindamycin | – | – | 1 | 5 | – | 6 |
Tetracycline |
22/23† |
– |
1 |
2/7† |
5/7† |
29/38† |
Isolates, % (no./total) | 24.5% (25/102) | 3.2% (8/251) | 10.8% (4/37) | 17.3% (18/104)‡ | 4.3% (9/211) | 9.1% (64/705) |
p value | <0.01 | <0.01 | <0.01 |
*Dashes indicate no isolates were drug resistant.
†Intermediate resistance. With fractions, the numerator indicates the number of isolates with intermediate resistance, and the denominator indicates the total number of resistant isolates.
‡Numbers in column do not add up to 18 (the number of isolates) because of multidrug resistance.
1These authors contributed equally to this article.
Page created: March 16, 2017
Page updated: March 16, 2017
Page reviewed: March 16, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.